Csnk1e is a genetic regulator of sensitivity to psychostimulants and opioids. - sprookjes - yvandenbroek - TriplyDB

Csnk1e is a genetic regulator of sensitivity to psychostimulants and opioids.

Csnk1e is a genetic regulator of sensitivity to psychostimulants and opioids.

http://www.wikidata.org/entity/Q34233183

about

The CK1 Family: Contribution to Cellular Stress Response and Its Role in Carcinogenesis Association of novelty-related behaviors and intravenous cocaine self-administration in Diversity Outbred mice.Hrr25/CK1δ-directed release of Ltv1 from pre-40S ribosomes is necessary for ribosome assembly and cell growth Hnrnph1 Is A Quantitative Trait Gene for Methamphetamine Sensitivity Fronto-temporal-mesolimbic gene expression and heritable differences in amphetamine-disrupted sensorimotor gating in rats.Characterization of Highper, an ENU-induced mouse mutant with abnormal psychostimulant and stress responses.High-resolution genetic mapping of complex traits from a combined analysis of F2 and advanced intercross mice Circadian rhythms and addiction: mechanistic insights and future directions QTL mapping in outbred populations: successes and challenges.Dopaminergic pathway polymorphisms and heroin addiction: further support for association of CSNK1E variants.The heritability of oxycodone reward and concomitant phenotypes in a LG/J × SM/J mouse advanced intercross line.Polymorphism in the serotonin receptor 2a (HTR2A) gene as possible predisposal factor for aggressive traits.Overlapping dopaminergic pathway genetic susceptibility to heroin and cocaine addictions in African Americans.Methamphetamine-induced conditioned place preference in LG/J and SM/J mouse strains and an F45/F46 advanced intercross line Cytogenetic risks and possible adverse health effects by narcotic substances dependent.Candidate SNP Markers of Chronopathologies Are Predicted by a Significant Change in the Affinity of TATA-Binding Protein for Human Gene Promoters.Translational genetic approaches to substance use disorders: bridging the gap between mice and humans.The circadian clock gene Csnk1e regulates rapid eye movement sleep amount, and nonrapid eye movement sleep architecture in mice.A population-based association study of casein kinase 1 epsilon loci with heroin dependence in Han Chinese.Genetic factors involved in risk for methamphetamine intake and sensitization.Inhibition of the casein-kinase-1-ε/δ/ prevents relapse-like alcohol drinking.Casein kinase 1-epsilon deletion increases mu opioid receptor-dependent behaviors and binge eating1.Drosophila: An Emergent Model for Delineating Interactions between the Circadian Clock and Drugs of Abuse.

P2860

Q21129297-B2FD49DB-8423-4731-9D86-CA2483AC3758 Q27325276-622A8D03-25DF-4BD3-BFDD-BAA0347F01FE Q27930417-CC3064DF-90C5-4232-86CE-690BFCFD2110 Q28551468-0976CAD4-CECD-41EC-A2B5-42EA08AD7F0F Q30366139-CBB52552-412F-4858-8DD2-182D4D6036BF Q30531391-8676F84B-B70C-4610-94CB-EDE02A07BCF2 Q30587743-74D0126E-8DFD-4412-B448-E4E3C07B5D9A Q33700259-270AB6F7-FA27-4404-8556-BB14DDF6EF83 Q33816498-CF853706-6F1C-4F11-AFB1-12C8AD1B1037 Q34891066-1067C374-4568-435D-9C24-7106964A286D Q34991740-01A533A5-509D-4BB4-9401-FC08452A9B73 Q35058108-459A9C00-B7BB-47F4-B6ED-8B4449C95A49 Q35439069-69E436D3-2296-46A0-AC48-F9014F2854FB Q36087398-1F64A0C8-51C2-4F88-82DD-2C0870E36497 Q36242650-0A202313-7122-4E00-A6DA-A538D67128E8 Q37231785-AC78FF30-142B-4A3C-AB9B-B342B5FFCE9D Q37968513-71E17B79-3037-4E42-ACE6-19D37F53A574 Q38586624-EB0C0441-0565-4F9F-90E8-AAA397E2C4E8 Q39294882-9584D3AC-0751-4E19-B088-8D9A34759140 Q41850242-411EFD96-EA07-4272-A921-BF1AE066FC73 Q42185453-B56CB58A-7CD6-4BDD-8D26-67C352CBE16E Q44346336-05632B2F-484A-4F28-A595-162390264F1F Q47637909-8710A58C-2D5B-466E-AFE8-E7FB5F00171B

P2860

Csnk1e is a genetic regulator of sensitivity to psychostimulants and opioids.

http://www.wikidata.org/entity/Q34233183

description

2011 nî lūn-bûn

@nan

2011 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած

@hyw

2011 թվականի նոյեմբերին հրատարակված գիտական հոդված

@hy

2011年の論文

@ja

2011年論文

@yue

2011年論文

@zh-hant

2011年論文

@zh-hk

2011年論文

@zh-mo

2011年論文

@zh-tw

2011年论文

@wuu

name

Csnk1e is a genetic regulator of sensitivity to psychostimulants and opioids.

@ast

Csnk1e is a genetic regulator of sensitivity to psychostimulants and opioids.

@en

Csnk1e is a genetic regulator of sensitivity to psychostimulants and opioids.

@nl

type

label

Csnk1e is a genetic regulator of sensitivity to psychostimulants and opioids.

@ast

Csnk1e is a genetic regulator of sensitivity to psychostimulants and opioids.

@en

Csnk1e is a genetic regulator of sensitivity to psychostimulants and opioids.

@nl

prefLabel

Csnk1e is a genetic regulator of sensitivity to psychostimulants and opioids.

@ast

Csnk1e is a genetic regulator of sensitivity to psychostimulants and opioids.

@en

Csnk1e is a genetic regulator of sensitivity to psychostimulants and opioids.

@nl

P1433

Q34233183-ACFE02D2-E94F-4B82-A49B-C7CC4132C644

P1476

Q34233183-A58E2B9E-DEAE-4C4D-847E-B835485BDD77

P2093

Q34233183-202537C8-AC0D-4F38-B2AD-093F545080F6

Q34233183-6D66236D-972B-4B59-8797-ACB00F1952CF

Q34233183-714298BA-9113-490B-A6A6-18ADF80AFD6C

Q34233183-7A75025D-CD92-4542-8E93-A8A7152988AD

Q34233183-98E37B76-AF05-4778-B1FD-184D33028D4F

Q34233183-AEC08CD2-C9E0-4C4C-8284-3C4F88930B9A

Q34233183-D3472B4D-8278-409E-8FA7-AA6019469D7B

Q34233183-DC235924-63E8-46AD-B817-34352C4CFC6B

Q34233183-F8906436-384E-4063-90BC-CED040E82775

P2860

Q34233183-0C6825CD-0957-4520-B117-F8F494D3BB7D

Q34233183-0DE245C4-A03E-4AF4-AF5E-9697BC1436E1

Q34233183-0E53D593-5F8A-4949-92C5-86ABDE64134C

Q34233183-105D136E-E9BA-4537-90FE-61F96375F134

Q34233183-129DC314-679B-4696-8CFE-90F2A09F00F4

Q34233183-15F625A6-EDF5-49A6-9CB7-D12DC14A925B

Q34233183-164AC5C1-07FE-4CAC-A3B7-9E2238A8275D

Q34233183-1AB47339-A847-4B46-B0B6-A5010DF0DF6A

Q34233183-2130AA08-2C31-4B1A-AE83-8C12AFC9C7B0

Q34233183-305D64DD-F176-41B7-BCB1-31D01D6D7353

P2888

Q34233183-649DF7E2-8552-49F3-B818-28A2208D14FD

P304

Q34233183-B621DB45-71B8-43E3-89C0-9FE07D3367A1

P31

Q34233183-03CF045D-3F77-4B81-99DF-66881DAE0393

P356

Q34233183-75DC833B-595F-42AF-8A7A-759913C368E4

P407

Q34233183-DD7F26AC-24E9-4F2E-A109-E9C3546FE7D7

P433

Q34233183-C3FC6140-3EAF-4C8E-B7C7-1C60D6074FA2

P478

Q34233183-0266DDCB-E26A-47E6-A336-1085ADBCE07B

P50

Q34233183-2533CB47-8CDF-457C-B533-41995584CCD6

Q34233183-85619663-ED26-404D-9569-9AD212E2CAE0

P577

Q34233183-10F02AE8-5709-4768-8253-BC1EF677C7D7

P5875

Q34233183-5779E061-03AC-4639-B06A-FB035AEE69C3

P6179

Q34233183-59F90F52-AFEB-4B8B-9B71-49F52414A6E2

P698

Q34233183-06CB0BD4-2DC9-4E92-90FB-1CA2EBB9A560

P921

Q34233183-1BDC6F3A-5C30-454A-965A-A78234B8007A

Q34233183-352F9C06-C451-4727-A848-B8B9BA5CFD89

P932

Q34233183-CEE1C6D8-6C6C-4D44-A48D-8C10D6C796F6

P356

P1433

Neuropsychopharmacology

P1476

Csnk1e is a genetic regulator of sensitivity to psychostimulants and opioids

@en

P2093

Abraham A Palmer

http://www.w3.org/2001/XMLSchema#string

Christopher Olker

http://www.w3.org/2001/XMLSchema#string

Clarissa C Parker

http://www.w3.org/2001/XMLSchema#string

Fred W Turek

http://www.w3.org/2001/XMLSchema#string

Lili Zhou

http://www.w3.org/2001/XMLSchema#string

Martha H Vitaterna

http://www.w3.org/2001/XMLSchema#string

Ramalakshmi Y Chandrasekaran

http://www.w3.org/2001/XMLSchema#string

Travis T Wager

http://www.w3.org/2001/XMLSchema#string

Valerie J Bolivar

http://www.w3.org/2001/XMLSchema#string

P2860

Setting clock speed in mammals: the CK1 epsilon tau mutation in mice accelerates circadian pacemakers by selectively destabilizing PERIOD proteins

Genetic susceptibility to heroin addiction: a candidate gene association study

Entrainment of disrupted circadian behavior through inhibition of casein kinase 1 (CK1) enzymes

An inhibitor of casein kinase I epsilon induces phase delays in circadian rhythms under free-running and entrained conditions

A translational profiling approach for the molecular characterization of CNS cell types

Mouse genomic variation and its effect on phenotypes and gene regulation

Drugs abused by humans preferentially increase synaptic dopamine concentrations in the mesolimbic system of freely moving rats

Breaking barriers in the genomics and pharmacogenetics of drug addiction

Is glycogen synthase kinase-3 a central modulator in mood regulation?

High-throughput behavioral phenotyping in the expanded panel of BXD recombinant inbred strains.

P2888

P304

1026-1035

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1038/NPP.2011.287

http://www.w3.org/2001/XMLSchema#string

P407

P433

4

http://www.w3.org/2001/XMLSchema#string

P478

37

http://www.w3.org/2001/XMLSchema#string

P50

Camron D Bryant

Andrew S Loudon

P577

2011-11-16T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

51803915

http://www.w3.org/2001/XMLSchema#string

P6179

1044234215

http://www.w3.org/2001/XMLSchema#string

P698

22089318

http://www.w3.org/2001/XMLSchema#string

P921

P932

3280656

http://www.w3.org/2001/XMLSchema#string